CUSIP 92337C104COMVSTMQ2 2025
34 filings · latest Feb 14, 2023
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Accent Capital Management, LLC | 52 | $5.3K |
| 4 | Jul 8, 2022 | Blackrock Inc. | 13G | 2.3% | 4.34M | SEC |
| 5 | Feb 14, 2022 | Baker Bros. Advisors LP | 13G/A | 11.8% | 21.49M | SEC |
| 6 | Feb 10, 2022 | Vanguard Group Inc | 13G/A | 4.9% | 8.85M | SEC |
| 7 | Feb 3, 2022 | Blackrock Inc. | 13G/A | 6.8% | 12.33M | SEC |
| 8 | Jan 10, 2022 | Biotechnology Value Fund L P | 13G/A | 5.3% | 9.58M | SEC |
| 9 | Jan 10, 2022 | Biotechnology Value Fund L P | 13G/A | 4.8% | 8.82M | SEC |
| 10 | May 10, 2021 | Baker Bros. Advisors LP | 13G/A | 10.9% | 18.69M | SEC |
See the full Schedule 13D/13G history for Verastem Inc.
Unlock full history